AZN - Nona Biosciences and AstraZeneca sign global license and option agreement
2024-05-23 03:20:19 ET
More on AstraZeneca
- AstraZeneca: A Triple Shot Of Income, Growth, And Value
- AstraZeneca: Strong In A Weak Market
- AstraZeneca PLC (AZN) Q1 2024 Earnings Call Transcript
- AstraZeneca projects $80B in revenue by 2030
- AstraZeneca, Amgen release mid-stage data on Tezspire for COPD